This article first appeared on GuruFocus. Aurora Cannabis Inc (TSX:ACB) is set to release its Q2 2026 earnings on Nov 5, 2025 ...

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Aurora Cannabis (TSX:ACB) remains unprofitable, but has managed to reduce its losses at an impressive rate of 61.2% per year ...

Aurora Cannabis Inc. is rated a Buy with 40% upside in current levels and expects solid growth in medical cannabis sales.

Aurora Cannabis reports Q2-2026 revenue growth with stronger international sales but posts net loss and negative free cash flow. Learn why ACB stock is a hold.

VN-Index continues to fall nearly 23 points; OPEC+ suspends oil production increase after December due to oversupply concerns ...

Vingroup group accelerates, VN-Index increases beyond 1,630 points; Ho Chi Minh City: Newly established enterprises decrease ...

Credit growth of 18-20% for 2025 appears achievable as banks’ outstanding loans continued to expand over the first nine ...

Amgen (AMGN) announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha achieved statistically significant ...

On a weekly basis ending on Friday, the Indian benchmark indices ended in green. Sensex and Nifty were up 1.6% each while ...